Primecap Management Co. CA Acquires 72,499 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)

Key Points

• Primecap Management Co. CA increased its stake in Health Catalyst, Inc. by 3.8% during the 1st quarter, owning 2,005,116 shares valued at approximately $9,083,000.
• Institutional investors hold 85% of Health Catalyst's stock, indicating strong interest from large financiers.
• Analysts have mixed opinions on Health Catalyst's stock price targets, with estimates varying from $4.00 to $9.00, and an average consensus rating of "Moderate Buy."

Primecap Management Co. CA raised its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 3.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,005,116 shares of the company's stock after purchasing an additional 72,499 shares during the quarter. Primecap Management Co. CA owned about 2.86% of Health Catalyst worth $9,083,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in HCAT. Probity Advisors Inc. increased its position in shares of Health Catalyst by 18.3% during the first quarter. Probity Advisors Inc. now owns 36,313 shares of the company's stock worth $164,000 after acquiring an additional 5,621 shares during the last quarter. XTX Topco Ltd acquired a new position in Health Catalyst in the first quarter worth about $54,000. Pier 88 Investment Partners LLC grew its stake in Health Catalyst by 34.5% in the first quarter. Pier 88 Investment Partners LLC now owns 229,870 shares of the company's stock worth $1,041,000 after purchasing an additional 58,980 shares in the last quarter. MCF Advisors LLC acquired a new position in Health Catalyst in the first quarter worth about $113,000. Finally, AMH Equity Ltd acquired a new position in Health Catalyst in the first quarter worth about $1,144,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Health Catalyst Price Performance

NASDAQ:HCAT traded up $0.15 during midday trading on Tuesday, hitting $2.85. 797,238 shares of the stock were exchanged, compared to its average volume of 695,828. The company has a market capitalization of $198.01 million, a price-to-earnings ratio of -1.88 and a beta of 1.46. Health Catalyst, Inc. has a one year low of $2.52 and a one year high of $9.24. The business has a 50-day moving average price of $3.82 and a two-hundred day moving average price of $4.23. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.40.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HCAT shares. Evercore ISI decreased their price target on Health Catalyst from $5.00 to $4.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. Stifel Nicolaus decreased their target price on Health Catalyst from $5.50 to $4.50 and set a "hold" rating for the company in a research note on Friday. Canaccord Genuity Group decreased their target price on Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. BTIG Research downgraded Health Catalyst from a "buy" rating to a "neutral" rating in a research note on Tuesday, June 17th. Finally, Citigroup downgraded Health Catalyst from a "buy" rating to a "neutral" rating and decreased their target price for the company from $6.50 to $3.50 in a research note on Friday. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Health Catalyst has an average rating of "Hold" and a consensus price target of $6.18.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.